Professional Documents
Culture Documents
Insight Into Autoproteolytic Activation From The Structure of Cephalosporin Acylase A Protein With Two Proteolytic Chemistries
Insight Into Autoproteolytic Activation From The Structure of Cephalosporin Acylase A Protein With Two Proteolytic Chemistries
Edited by Earl W. Davie, University of Washington, Seattle, WA, and approved December 19, 2005 (received for review September 12, 2005)
Cephalosporin acylase (CA), a member of the N-terminal nucleo- between Gly-169 and Ser-170 generates the ␣⬘ subunit (the ␣
phile hydrolase family, is activated through sequential primary and subunit with a 9-aa pro segment) and the  subunit. A subsequent
secondary autoproteolytic reactions with the release of a pro secondary autocleavage between Gly-160 and Asp-161 releases the
segment. We have determined crystal structures of four CA mu- pro segment from the ␣⬘ subunit, resulting in an active heterotet-
tants. Two mutants are trapped after the primary cleavage, and the ramer (␣)2. The release of the pro segment may be required for
other two undergo secondary cleavage slowly. These structures optimal CA activity. Ser-170, which becomes the N-terminal resi-
provide a look at pro-segment conformation during activation in due (Ser-1)†† of the  subunit of CA is invariant and known to play
N-terminal nucleophile hydrolases. The highly strained helical pro a critical role in both autoproteolytic activation and enzyme catal-
segment of precursor is transformed into a relaxed loop in the ysis (23–25).
intermediates, suggesting that the relaxation of structural con- In an effort to gain a better understanding of the autoproteolyic
straints drives the primary cleavage reaction. The secondary auto- mechanism, we have designed constructs containing mutations that
proteolytic step has been proposed to be intermolecular. However, partially prevent or retard autocleavage and carried out the struc-
our analysis provides evidence that CA is processed in two sequen- tural determination of these mutants. Here, we report structural
tial steps of intramolecular autoproteolysis involving two distinct evidence that CA is processed in two sequential steps of intramo-
residues in the active site, the first a serine and the second a lecular autoproteolysis involving two distinct proteolytic mecha-
glutamate. nisms, the first mediated by a serine residue and the second by a
glutamate.
autoproteolysis 兩 precursor activation 兩 intermediate structure 兩
pro segment Results
Choice of Mutant Proteins. A single amino acid mutation of
Ser-170 to alanine (S170A) prevents primary cleavage, pro-
P osttranslational autoproteolysis is a mechanism used to activate
many proteins via self-catalyzed peptide bond rearrangements,
which play an essential role in a wide variety of biological processes.
ducing an enzymatically inactive single-polypeptide precursor
(Fig. 1B). The crystal structures of precursor (S170A) and
They include activation cascades such as blood coagulation and mature CA have been reported (11). In this study, we have
fibrinolysis, cell death, embryonic development, protein targeting focused mainly on four mutants. S170C and E159Q underwent
and degradation, viral protein processing, and zymogen activation primary autocleavage but no secondary autocleavage. Y202L
(1–6). Increasing evidence suggests that autoproteolysis may be and R226K, slow processing mutants, showed a delayed release
involved in more biological activation processes than previously of the pro segment in comparison with the mature enzyme.
appreciated. These processes are all mediated by intramolecular or Tyr-202 and Arg-226 are located in the substrate binding site
intermolecular autocleavage reactions. Four types of intramolecu- of CA. The Y202L and R226K mutants were initially analyzed
lar protein modifications have been studied extensively: hedgehog as altered-activity mutants and found to be capable of sequen-
proteins, inteins, N-terminal nucleophile (Ntn) hydrolases, and tially producing ␣⬘ and ␣ subunits during activation. In the case
pyruvoyl enzymes (4, 7–9). of Y202L, it took ⬇24 h at 37°C to make a complete transition
Members of the Ntn hydrolase family have divergent sequences, from the uncleaved to the cleaved form (Fig. 1C, Y202L
but share an ␣␣ sandwich structural motif and a common control). Thus, early (Y202L) and late (Y202L,L) stages of
enzyme mechanism (7, 8). In addition, they catalyze internal
peptide bond rearrangement through an N 3 O or N 3 S acyl shift
Conflict of interest statement: No conflicts declared.
by a nucleophilic Ntn amino acid created by autoproteolytic pro-
This paper was submitted directly (Track II) to the PNAS office.
cessing (4, 7). Structures of mature Ntn hydrolases, including
cephalosporin acylase (CA), penicillin G acylase (PA), penicillin V Abbreviations: CA, cephalosporin acylase; Ntn, N-terminal nucleophile.
acylase, glutamine 5-phosphoribosyl-1-pyrophosphate amidotrans- Data deposition: The atomic coordinates have been deposited in the Protein Data Bank,
ferase, 20S proteasome  subunit (PRO), glycosylasparaginase www.rcsb.org (PDB ID codes 2ADV, 2AE5, 2AE4, and 2AE3 for Y202L, S170C, E159Q, and
R226K, respectively).
(GA), and L-aminopeptidase, have been determined (10–17). †J.K.K. and I.S.Y. contributed equally to this work.
Structures of the precursors of CA, PA, PRO, and GA have been §Present address: Department of Chemistry, Pohang University of Science and Technology,
reported, providing some insight into the activation mechanism (11, Pohang 790-784, Korea.
18–22). However, the understanding of mechanism cannot be ¶Present address: Department of Microbiology and Immunology, College of Medicine,
complete without structural information on the first cleavage Catholic University, Seoul 137-701, Korea.
intermediates. **To whom correspondence should be addressed. E-mail: khkim@korea.ac.kr.
Ntn hydrolases are of particular interest because they include ††The amino acid residue is numbered according to the precursor (residues 1– 691) com-
acylase enzymes used in the biosynthesis of the -lactam antibiotics prising the ␣ subunit (residues 1–160), the pro-segment region (residues 161–169), and
cephalosporin and penicillin. We have focused on CA. This enzyme the  subunit (residues 170 – 691). The amino acid residue of the mature subunit (precursor
is expressed as a 76-kDa precursor that is activated by two sequen- number minus 169) is numbered in parentheses, if applicable.
tial autocleavage steps (11, 23) (Fig. 1A). A primary cleavage © 2006 by The National Academy of Sciences of the USA
57) in the substrate binding site (Fig. 4). Similar interactions are fairly similar to that of the Y202L and R226K forms (Fig. 3).
recognized as crucial for the structural stabilization of caspase BIR Based on the intermediate structures, we therefore propose that
domain (28) and neutrophil collagenase (29). Moreover, (Phe-177) CA may have evolved separate autoproteolytic mechanisms, the
is the only residue of 682 modeled amino acid residues in a first a serine proteolysis and the second a carboxyl proteolysis.
disallowed region of the Ramachandran plot in all mutant crystal Upon protein folding, precursor CA undergoes the primary auto-
proteolysis that uses a N 3 O acyl shift (Fig. 5A). Initially, a Analysis of Autocleavage. The extent of primary and secondary
high-energy state of the pro segment caused by conformational autocleavage for the purified mutants was analyzed by SDS兾PAGE.
constraints may trigger a peptide flip. WAT1, held by hydrogen Y202L showed an approximately equimolar mixture of cleaved and
bonds in pseudotetrahedral geometry, acts as a general base to uncleaved ␣ subunits subsequent to purification (Y202L early:
deprotonate the hydroxyl group of Ser-170 to enhance its nucleo- Y202L). Both the ␣ subunit linked with the pro segment (␣⬘
philicity. The hydroxyl group carries out the nucleophilic attack on subunit) and the ␣ subunit itself were subjected to MALDI-TOF
the peptide bond between Gly-169 and Ser-170. This primary mass spectrometry (Korea Basic Research Institute, Seoul). The
time-course monitoring of in vitro secondary processing of S170C
cleavage results in generating a helix-to-loop transition of the pro
or Y202L was carried out in 20 mM Tris (pH 8.0) at 37°C for 24 h.
segment, which consequently triggers an activation signal switch for
S170C remained in the uncleaved form because of the lack of
initiation of the secondary carboxyl autoproteolysis. Glu-159 acting secondary cleavage. For Y202L, it took ⬇24 h at 37°C, to make a
as a general base may accept a proton from WAT1 to enhance its complete transition from the uncleaved to the cleaved form (Y202L
nucleophilicity (Fig. 5B). The nucleophilic attack on the peptide late: Y202L,L). From the solution processed at 37°C, 5-l aliquots
bond between Gly-160 and Asp-161 is carried out by WAT1, were sampled at 3-h intervals. The addition of the mature enzyme
producing a tetrahedral transition state. Formation of the ester to each mutant solution or 0.1 M 1-ethyl-3-(3-dimethylaminopro-
intermediate (a N 3 O acyl shift) requires stabilization of the pyl) carbodiimide (EDC) to Y202L in 1.0 M glycine ethyl ester at
oxyanionic transition state, which may be undertaken by the pH 5.0 at 25°C was used to detect changes in secondary processing.
backbone nitrogen of Arg-155. The secondary autoproteolysis For pH analysis of the secondary autocleavage of Y202L, time-
results in cleavage and subsequent dissociation of the pro segment, course monitoring was carried out at different pH values, ranging
producing the ␣ subunit. Autoproteolytic cleavage in Ntn hydro- from 5.0 to 8.0. For reconstitution experiments, ␣, ␣⬘, or  subunit
lases is mediated by intramolecular autocleavage reactions. CA then was separately purified from mature CA, S170C, and E159Q in the
1. Davie, E. W. (1995) Thromb. Haemostasis 74, 1–6. 21. Xu, Q., Buckley, D., Guan, C. & Guo, H. (1999) Cell 98, 651–661.
2. Salvesen, G. S. & Dixit, V. M. (1999) Proc. Natl. Acad. Sci. USA 96, 10964–10967. 22. Albert, A., Dhanaraj, V., Genschel, U., Khan, G., Ramjee, M. K., Pulido, R., Sibanda, B. L.,
3. Dissing, M., Giordano, H. & DeLotto, R. (2001) EMBO J. 20, 2387–2393. von Delft, F., Witty, M. & Blundell, T. L., et al. (1998) Nat. Struct. Mol. Biol. 5, 289–293.
4. Perler, F. B. (1998) Cell 92, 1–4. 23. Lee, Y. S. & Park, S. S. (1998) J. Bacteriol. 180, 4576–4582.
5. Babe, L. M. & Craik, C. S. V. (1997) Cell 91, 427–430. 24. Fritz-Wolf, K., Koller, K. P., Lange, G., Liesum, A., Sauber, K., Schreuder, H., Arets, W.
6. Kahn, A. R. & James, M. N. G. (1998) Protein Sci. 7, 815–836. & Kabsch, W. (2002) Protein Sci. 11, 92–103.
7. Perler, F. B. (1998) Nat. Struct. Mol. Biol. 5, 249–252. 25. Kim, S. & Kim, Y. (2001) J. Biol. Chem. 276, 48376–48381.
8. Brannigan, J. A., Dodson, G., Duggleby, H. J., Moody, P. C., Smith, J. L., Tomchick, D. R. 26. Qian, X. Q., Guan, C. & Guo, H. (2003) Structure (London) 11, 997–1003.
& Murzin, A. G. (1995) Nature 378, 416–419. 27. Zacharia, N. & Dougherty, D. A. (2002) Trends Pharmacol. Sci. 23, 281–287.
9. van Poelje, P. D. & Snell, E. E. (1990) Biochemistry 29, 132–139. 28. Luque, L. E., Grape, K. P. & Junker, M. (2002) Biochemistry 41, 13663–13671.
10. Kim, Y., Yoon, K., Khang, Y., Turley, S. & Hol, W. G. (2000) Structure (London) 8, 29. Gavuzzo, E., Pochetti, G., Mazza, F., Gallina, C., Gorini, B., D’Alessio, S., Pieper, M.,
1059–1068. Tschesche, H. & Tucker, P. A. (2000) J. Med. Chem. 43, 3377–3385.
11. Kim, J. K., Yang, I. S., Rhee, S., Dauter, Z., Lee, Y. S., Park, S. S. & Kim, K. H. (2003) 30. Tanner, K. G., Trievel, R. C., Kuo, M. H., Howard, R. M., Berger, S. L., Allis, C. D.,
Biochemistry 42, 4084–4093. Marmorstein, R. & Denu, J. M. (1999) J. Biol. Chem. 274, 18157–18160.
12. Duggleby, H. J., Tolley, S. P., Hill, C. P., Dodson, E. J., Dodson, G. & Moody, P. C. (1995) 31. Weston, S. A., Camble, R., Colls, J., Rosenbrock, G., Taylor, I., Egerton, M., Tucker, A. D.,
Nature 373, 264–268. Tunnicliffe, A., Mistry, A., Mancia, F., et al. (1998) Nat. Struct. Mol. Biol. 5, 213–221.
13. Suresh, C. G., Pundle, A. V., SivaRaman, H., Rao, K. N., Brannigan, J. A., McVey, C. E., 32. Lewendon, A., Murray, I. A., Shaw, W. V., Gibbs, M. R. & Leslie, A. G. (1994) Biochemistry
Verma, C. S., Dauter, Z., Dodson, E. J. & Dodson, G. G. (1999) Nat. Struct. Mol. Biol. 6, 33, 1944–1950.
414–416. 33. Otwinowski, Z. & Minor, W. (1997) Methods Enzymol. 276, 307–326.
14. Smith, J. L., Zaluzec, E. J., Wery, J. P., Niu, L., Switzer, R. L., Zalkin, H. & Satow, Y. (1994) 34. Brunger, A. T., Adams, P. D., Clore, G. M., Delano, W. L., Gros, P., Grosse-Kunstleve,
Science 264, 1427–1433. R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., et al. (1998) Acta Crystallogr. D
15. Lowe, J., Stock, D., Jap, B., Zwickl, P., Baumeister, W. & Huber, R. (1995) Science 268, 54, 905–921.
533–539. 35. Jones, T. A., Zou, J. Y., Cowan, S. W. & Kjeldgaard, M. (1991) Acta Crystallogr. A 47,
16. Oinonen, C., Tikkanen, R., Rouvinen, J. & Peltonen, L. (1995) Nat. Struct. Mol. Biol. 2, 110–119.
1102–1108. 36. Murshudov, G. N., Vagin, A. A. & Dodson, E. J. (1997) Acta Crystallogr. D 53, 240–255.
17. Bompard-Gilles, C., Villeret, V., Davies, G. J., Fanuel, L., Joris, B., Frere, J. M. & Van 37. Brunger, A. T. (1992) Nature 355, 472–475.
Beeumen, J. (2000) Structure (London) 8, 153–162. 38. Laskowski, R. A., MacArthur, M. W., Moss, D. S. & Thorton, J. M. (1993) J. Appl.
18. Kim, Y., Kim, S., Earnest, T. N. & Hol, W. G. J. (2001) J. Biol. Chem. 277, 2823–2829. Crystallogr. 26, 283–291.
19. Hewitt, L., Kasche, V., Lummer, K., Lewis, R. J., Murshudov, G. N., Verma, C. S., Dodson, 39. Kraulis, P. J. (1991) J. Appl. Crystallogr. 24, 946–950.
G. G. & Wilson, K. S. (2000) J. Mol. Biol. 302, 887–896. 40. Merritt, E. A. & Murphy, M. E. P. (1994) Acta Crystallogr. D 50, 869–873.
20. Ditzel, L., Huber, R., Mann, K., Heinemeyer, W., Wolf, D. H. & Groll, M. (1998) J. Mol. 41. DeLano, W. L. (2002) The PYMOL Molecular Graphics System (DeLano Scientific, San
Biol. 279, 1187–1191. Carlos, CA).
BIOPHYSICS